The Health Intervention and Technology Assessment Program (HITAP) was established in 2007 as a non-profit organization. Its main responsibility is to assess health interventions and technology assessment with the coverage of pharmaceuticals, medical devices, interventions, individual and community health promotions and disease prevention, as well a

This research and development project aims to (i) provide recommendations for development of the P&P policies for children aged 0-5 years old; (ii) develop mechanism for further development of the P&P policies for other groups of population that is systematic, evidence-based, transparent, participatory; (iii) establish health promotion and

The World Health Organization (WHO) requested HITAP to provide technical assistance to the Ministry of Health and Sports (MoHS) in Myanmar to complete a closure assessment of two health financing schemes under the GAVI Health Systems Strengthening Support (HSS) program. The study will apply a multi-pronged approach comprising a document review, a s

The HTAsiaLink Annual Conference for this year happened on 4 – 7 September, hosted by the Malaysia Health Technology Assessment Section (MaHTAS) under the Ministry of Health, Malaysia. Researchers from HITAP participated in the conference and presented their research projects thr

Angela is an International Cooperation Officer at the Health Intervention and Technology Assessment Program Foundation (HITAP), where she supports global partnerships and coordination of regional networks and platforms such as HTAsiaLink, SAPPHIRE, and GEAR. With a strong interest in bridging technical research and policy, she also contributes to r

In January 2019, the Minister of Health from Chhattisgarh state, India, reached out to International Health Policy Program (IHPP), a semi-autonomous research program in Thailand, to learn about the Thai experience of implementing Universal Health Coverage (UHC). The minister requested to meet with s

Patient’s perspectives can offer great insights into perceived benefits of health interventions and the challenges and obstacles encountered as a result of the healthcare system. Now at its 10th issue, the HTAsiaLink Newsletter focuses on the theme of Patient Involvement in Health Technology Assessm

As more countries provide free health care, pharmaceutical reimbursement lists are becoming a concern, especially in low- and middle-income countries. In 2007, Nepal decreed that health is a human right and began basic health coverage for a target group of the poor, destitute, elderly, and disabled.

Achieving universal health coverage (UHC) requires policy initiatives supported by long-term system reform and an accountable governance structure that can sustainably deliver all three dimensions of UHC, population coverage, breadth of benefits package, and degree of financial coverag

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q